GentiBio is a Massachusetts-based biotherapeutics company that develops regulatory T cells for the treatment of autoimmune, autoinflammatory and allergic diseases.
Business Model:
Revenue: $2.5M
Employees: 51-200
Address: 6 Tide Street
City: Boston
State: MA
Zip: 02110
Country: US
GentiBio is a Massachusetts-based biotherapeutics company that develops regulatory T cells for the treatment of autoimmune, autoinflammatory and allergic diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2020 | Seed Round | 3 | $20M |
RA Capital Management OrbiMed Novartis Venture Fund Novartis Venture Fund OrbiMed RA Capital Management RA Capital Management OrbiMed Novartis Venture Fund Novartis Venture Fund OrbiMed RA Capital Management |
8/2021 | Series A | 7 | $157M |
Avidity Partners JDRF T1D Fund Matrix Capital Management Novartis Venture Fund OrbiMed RA Capital Management Seattle Children&s;s Hospital and Research Institute Avidity Partners JDRF T1D Fund Matrix Capital Management Novartis Venture Fund OrbiMed RA Capital Management Seattle Children&s;s Hospital and Research Institute |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|